Skip to content
Peptides Codex

Use the arrow keys to choose a result, Enter to open it, and Escape to close.

← Home
Cluster

Metabolic & GLP-1 peptides

Incretins and metabolic peptides — GLP-1, semaglutide, tirzepatide, and related science.

In this cluster

52 peptide profiles

GLP-1

30 aa
Incretin

Glucagon-like peptide-1 (GLP-1) is a 30–31-residue incretin hormone released by intestinal L-cells after a meal. It potentiates glucose-depe…

Read profile →

Semaglutide

31 aa
Incretin analog

Semaglutide is a 31-amino-acid GLP-1 receptor agonist peptide (C187H291N45O59, ≈4,114 Da). It keeps 94% of the human GLP-1 sequence but subs…

Read profile →

MOTS-c

16 aa
Mitochondrial-derived peptide (research compound)

MOTS-c is a 16-amino-acid peptide (MRWQEMGYIFYPRKLR; C101H152N28O22S2, ≈2,175 Da) encoded by a short open reading frame inside the mitochond…

Read profile →

Exendin-4

39 aa
Incretin mimetic

Exendin-4 is a 39-residue peptide from Gila monster venom that activates the GLP-1 receptor and inspired the drug exenatide.

Read profile →

Tirzepatide

39 aa
Incretin dual agonist

Tirzepatide is a 39-amino-acid synthetic peptide (C225H348N48O68, ≈4,814 Da) that activates both the GIP and GLP-1 receptors. Its backbone i…

Read profile →

Retatrutide

39 aa
Incretin triple agonist

Retatrutide (LY3437943) is an investigational 39-amino-acid peptide (C221H342N46O68, ≈4,731 Da) that activates three receptors — GIP, GLP-1 …

Read profile →

AOD-9604

16 aa
Research peptide

AOD-9604 is a synthetic 16-residue peptide based on the C-terminal region of human growth hormone (residues 177–191 with an added N-terminal…

Read profile →

Cagrilintide

37 aa
Amylin analog (dual amylin / calcitonin receptor agonist)

Cagrilintide is an investigational 37-amino-acid analogue of the pancreatic hormone amylin (C194H312N54O59S2, ≈4,409 Da). Six substitutions …

Read profile →

Survodutide

29 aa
Dual GLP-1 / glucagon receptor agonist (investigational)

Survodutide (BI 456906) is an investigational 29-amino-acid glucagon-based peptide (C192H289N47O61, ≈4,232 Da) that activates both the gluca…

Read profile →

Mazdutide

34 aa
Dual GLP-1 / glucagon receptor agonist (oxyntomodulin analog)

Mazdutide (IBI362 / LY3305677) is a once-weekly oxyntomodulin-based peptide (C207H317N45O65, ≈4,476 Da) that activates the GLP-1 and glucago…

Read profile →

Adipotide

Chimeric pro-apoptotic peptidomimetic (investigational)

Adipotide (Prohibitin-TP01) is an experimental chimeric peptidomimetic that pairs a homing sequence targeting adipose-tissue blood vessels w…

Read profile →

Liraglutide

31 aa
GLP-1 receptor agonist (acylated peptide)

Liraglutide is a once-daily GLP-1 receptor agonist peptide: human GLP-1(7-37) with one substitution (Lys34→Arg) and a C16 palmitic acid atta…

Read profile →

Dulaglutide

GLP-1 receptor agonist (Fc-fusion protein; approved medicine)

Dulaglutide (Trulicity) is a once-weekly GLP-1 receptor agonist built as a fusion protein: two DPP-4-resistant GLP-1 analogue chains linked …

Read profile →

Setmelanotide

8 aa
Melanocortin-4 receptor (MC4R) agonist peptide

Setmelanotide is a synthetic cyclic octapeptide that selectively activates the melanocortin-4 receptor (MC4R), a signaling hub in the brain'…

Read profile →

Pramlintide

37 aa
Amylin analog

Pramlintide is a synthetic analog of the pancreatic hormone amylin, designed with proline substitutions so it stays soluble rather than aggr…

Read profile →

Amylin

37 aa
Hormone

Amylin, or islet amyloid polypeptide (IAPP), is a 37-residue peptide hormone co-secreted with insulin from pancreatic beta cells. It is stud…

Read profile →

Glucagon

29 aa
Hormone

Glucagon is a 29-amino-acid peptide hormone from pancreatic alpha cells that raises blood glucose, opposing insulin. It is the archetypal co…

Read profile →

Oxyntomodulin

37 aa
Gut hormone

Oxyntomodulin is a 37-amino-acid gut hormone released from intestinal L-cells after eating. Because it activates both the GLP-1 and glucagon…

Read profile →

GIP

42 aa
Incretin

GIP (glucose-dependent insulinotropic polypeptide) is a 42-amino-acid incretin hormone released from intestinal K-cells after meals, where i…

Read profile →

Secretin

27 aa
Hormone

Secretin is a 27-amino-acid hormone released from duodenal S-cells in response to stomach acid entering the small intestine. Discovered by B…

Read profile →

Motilin

22 aa
Gut hormone

Motilin is a 22-amino-acid gut hormone secreted by endocrine cells of the small intestine. It coordinates the migrating motor complex, the w…

Read profile →

Peptide YY

36 aa
Gut hormone

Peptide YY (PYY) is a 36-amino-acid gut hormone released from intestinal L-cells after eating, where it contributes to satiety and slows gas…

Read profile →

Obestatin

23 aa
Gut hormone

Obestatin is a 23-amino-acid peptide cleaved from the same preproghrelin precursor that produces ghrelin. It was originally proposed to oppo…

Read profile →

Nesfatin-1

82 aa
Neuropeptide / metabolic peptide

Nesfatin-1 is a peptide cleaved from the precursor protein nucleobindin-2 (NUCB2), produced in the hypothalamus and in peripheral tissues. I…

Read profile →

Cholecystokinin

8 aa
Gut & brain peptide

Cholecystokinin (CCK) is a peptide hormone and neurotransmitter released from intestinal I-cells and also produced widely in the brain. It t…

Read profile →

Gastrin

Gut hormone

Gastrin is a peptide hormone released by G-cells of the gastric antrum that stimulates acid secretion from the stomach's parietal cells. Cir…

Read profile →

Lixisenatide

44 aa
Incretin mimetic (GLP-1 receptor agonist)

Lixisenatide is a synthetic GLP-1 receptor agonist built on the exendin-4 scaffold rather than on human GLP-1. Marketed as Lyxumia and Adlyx…

Read profile →

Albiglutide

Incretin mimetic (GLP-1 receptor agonist)

Albiglutide is a GLP-1 receptor agonist created by genetically fusing two modified GLP-1 sequences to human serum albumin, giving it a long …

Read profile →

Efpeglenatide

Incretin mimetic (GLP-1 receptor agonist)

Efpeglenatide is a long-acting GLP-1 receptor agonist built from an exendin-based peptide conjugated to an antibody Fc fragment for extended…

Read profile →

Teduglutide

33 aa
GLP-2 analog

Teduglutide is a synthetic 33-amino-acid analog of glucagon-like peptide-2 (GLP-2). A single alanine-to-glycine substitution extends its hal…

Read profile →

Linaclotide

14 aa
Guanylate cyclase-C agonist

Linaclotide is a synthetic 14-amino-acid peptide that activates guanylate cyclase-C on the intestinal lining, raising cyclic GMP and driving…

Read profile →

Plecanatide

16 aa
Guanylate cyclase-C agonist

Plecanatide (Trulance) is a synthetic 16-residue analogue of human uroguanylin (NDECELCVNVACTGCL, two disulfides) that activates guanylate c…

Read profile →

Apelin

Peptide hormone

Apelin is an endogenous peptide hormone processed from a 77-amino-acid precursor into active fragments such as apelin-13 and apelin-36. It i…

Read profile →

Adropin

76 aa
Peptide hormone (hepatokine)

Adropin is a secreted peptide encoded by the energy homeostasis-associated gene (ENHO) and first described in 2008. Its 76-residue sequence …

Read profile →

Spexin

14 aa
Neuropeptide / peptide hormone

Spexin (neuropeptide Q) is a 14-amino-acid endogenous peptide discovered by bioinformatic analysis in 2007. It signals through galanin recep…

Read profile →

Glucagon-like peptide-2

33 aa
Peptide hormone (proglucagon-derived)

Glucagon-like peptide-2 (GLP-2) is a 33-amino-acid gut hormone produced from proglucagon in intestinal L cells and co-released with GLP-1. A…

Read profile →

Uroguanylin

16 aa
Signaling peptide (guanylin family)

Uroguanylin is a 16-amino-acid peptide secreted by enterochromaffin cells of the duodenum and encoded by GUCA2B. As an endogenous guanylate …

Read profile →

Cotadutide

30 aa
GLP-1 / glucagon receptor dual agonist (peptide)

Cotadutide (MEDI0382) is a synthetic peptide engineered as a balanced dual agonist of the GLP-1 and glucagon receptors. It is an investigati…

Read profile →

Pemvidutide

GLP-1 / glucagon receptor dual agonist (peptide)

Pemvidutide (ALT-801) is an investigational dual GLP-1/glucagon receptor agonist developed by Altimmune and studied in clinical trials for o…

Read profile →

Efinopegdutide

GLP-1 / glucagon receptor dual agonist

Efinopegdutide (MK-6024) is an investigational once-weekly GLP-1/glucagon receptor co-agonist peptide being developed by Merck for metabolic…

Read profile →

Beinaglutide

30 aa
GLP-1 receptor agonist (recombinant human GLP-1)

Beinaglutide is a recombinant human GLP-1(7-36) that shares 100% sequence identity with native human GLP-1. Approved in China for type 2 dia…

Read profile →

Amycretin

Unimolecular GLP-1 / amylin receptor co-agonist

Amycretin (NN9487) is an investigational Novo Nordisk peptide that activates both the GLP-1 receptor and amylin receptors from a single chai…

Read profile →

Exenatide

39 aa
GLP-1 receptor agonist (exendin-4 class)

Exenatide is the synthetic form of exendin-4, a 39-residue peptide from Gila monster venom that activates the GLP-1 receptor. It was the fir…

Read profile →

Maridebart cafraglutide

Antibody–peptide conjugate (GIPR antagonist antibody + GLP-1 agonist peptides)

Maridebart cafraglutide (MariTide, AMG 133) is an investigational antibody–peptide conjugate from Amgen: an antibody that antagonises the GI…

Read profile →

Petrelintide

36 aa
Long-acting lipidated amylin analogue (DACRA)

Petrelintide (ZP8396) is an investigational long-acting analogue of human amylin developed by Zealand Pharma as a dual amylin and calcitonin…

Read profile →

Eloralintide

Selective long-acting amylin receptor agonist

Eloralintide (LY3841136) is an investigational once-weekly amylin analogue from Eli Lilly that preferentially activates the amylin 1 recepto…

Read profile →

Ecnoglutide

cAMP-biased GLP-1 receptor agonist

Ecnoglutide (XW003) is a long-acting, cAMP-biased GLP-1 receptor agonist from Sciwind Biosciences: a human GLP-1 analogue with an Ala8Val su…

Read profile →

Dapiglutide

Dual GLP-1 / GLP-2 receptor agonist

Dapiglutide (ZP7570) is an investigational long-acting peptide from Zealand Pharma that activates both the GLP-1 and GLP-2 receptors, aiming…

Read profile →

Dasiglucagon

29 aa
Glucagon analogue

Dasiglucagon (Zegalogue) is a 29-amino-acid glucagon analogue with seven amino-acid substitutions, including Aib at position 16, that make i…

Read profile →

Glepaglutide

39 aa
GLP-2 analogue

Glepaglutide (ZP1848) is a 39-amino-acid long-acting analogue of glucagon-like peptide-2 with a C-terminal hexa-lysine extension, developed …

Read profile →

Apraglutide

33 aa
GLP-2 analogue

Apraglutide (FE 203799) is a synthetic 33-amino-acid analogue of glucagon-like peptide-2 with four substitutions (Ala2→Gly, Met10→Ahx, Asn11…

Read profile →

C-peptide

31 aa
Proinsulin connecting peptide

C-peptide is the 31-amino-acid connecting peptide released when proinsulin is cleaved into insulin, produced in equimolar amounts with insul…

Read profile →

The incretin & metabolic co-agonist class at a glance

PeptideReceptorsLengthMass (Da)Half-lifeStatus
GLP-1GLP-1R30 aa≈ 3,297.6≈ 1–2 min (DPP-4 cleavage + renal clearance)Endogenous hormone — not a product
LiraglutideGLP-1R31 aa≈ 3,751.2≈ 13 h (once-daily dosing)Approved: Victoza (2010, T2D), Saxenda (2014, weight)
SemaglutideGLP-1R31 aa≈ 4,113.6≈ 7 days (≈ 145–165 h in clinical PK studies)Approved: Ozempic (2017, T2D), Rybelsus (2019, oral T2D), Wegovy (2021, weight)
TirzepatideGIPR + GLP-1R39 aa≈ 4,813.5≈ 5 days (≈ 117 h)Approved: Mounjaro (2022, T2D), Zepbound (2023, weight; 2024, obstructive sleep apnoea)
RetatrutideGIPR + GLP-1R + GCGR39 aa≈ 4,731≈ 6 daysInvestigational (phase 3)
CagrilintideAmylin / calcitonin37 aa≈ 4,409≈ 7–8 days (159–195 h across doses in the phase 1b study)Investigational (phase 3, as CagriSema with semaglutide)
SurvodutideGCGR + GLP-1R29 aa≈ 4,232Supports once-weekly dosing (published population estimates are on the order of several days)Investigational (phase 3: SYNCHRONIZE obesity programme; MASH programme)
MazdutideGCGR + GLP-1R34 aa≈ 4,476Supports once-weekly dosing (published estimates are on the order of several days)Approved in China (NMPA): chronic weight management (27 June 2025) and type 2 diabetes (2025)
AmycretinGLP-1R + amylin——Supports once-weekly subcutaneous dosingInvestigational (phase 2 results published 2025; later-phase trials under way)

Verified from PubChem, IUPHAR and the primary discovery papers cited on each profile. Half-lives are approximate population means from published pharmacokinetics.

You might also like: Overview · Types · Peptide Atlas · Research · Glossary · Resources
Cite this: Peptides Codex — Topic cluster (educational).
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.